Table 3 Association of PRKCE variant rs1553369874 with HCV-induced HCC stages
Genotype | Frequency Distribution % | Odds Ratio | Relative Risk | P value | |||
|---|---|---|---|---|---|---|---|
Patients | Control | Value | 95% CI | Value | 95% CI | ||
AA (stage 1&2) | 14.29% | 32.32% | 0.3490 | 0.1476 to 0.7616 | 0.4919 | 0.2615 to 0.8597 | 0.0101 |
GG (stage 1&2) | 76.19% | 38.00% | 5.221 | 2.538 to 10.70 | 2.865 | 1.793 to 4.733 | < 0.0001 |
AG (stage 1&2) | 9.52% | 30.00% | 0.2456 | 0.09984 to 0.6320 | 0.3713 | 0.1717 to 0.7348 | 0.0019 |
AA (stage 3&4) | 18.92% | 32.32% | 0.4885 | 0.1934 to 1.169 | 0.5803 | 0.2751 to 1.146 | 0.1410 |
GG (stage 3&4) | 64.86% | 38.00% | 3.012 | 1.396 to 6.627 | 2.233 | 1.263 to 4.013 | 0.0067 |
AG (stage 3&4) | 16.22% | 30.00% | 0.4516 | 0.1752 to 1.152 | 0.5430 | 0.2444 to 1.119 | 0.1280 |